| 영문 | pneumonia | 한글 | 폐렴 |
|---|---|---|---|
| 설명 | 폐의 염증으로 폐포 내에 공기 대신 염증 세포나 삼출액으로 가득 차 호흡곤란을 야기하며, 발열 등의 전신 증상을 동반한다. 위치, 원인균 등에 따라 구분한다. 예를 들어, 대엽성 폐렴(lobar pneumonia)란 폐렴 구균에 의한 급성 페렴으로 한 개 또는 여러 개의 폐엽을 따라 생기는 광범위한 삼출성 경화가 특징인 병을 지칭한다. 이것은 폐렴의 발생부위에 따라 부르는 말이다. 그리고 바이러스폐렴(viral pneumonia)란 바이러스에 의해 발생하는 모든 폐렴을 말하는데, 이것은 원인균에 따라 지칭한 말이다. |
||
| 영문 | aspiration pneumonia | 한글 | 흡인폐렴 |
|---|---|---|---|
| 설명 | 음식물의 찌꺼기같은 이물이 기도에 들어가 이차적으로 생기는 폐렴. 음식물이나 입안의 미생물이 식도로 넘어가지 않고 기도로 잘못 흡인되어 야기되는 폐렴을 말한다. 흡인 물질의 특성에 따라서 세 가지 증후군을 포함한다. ① 화학적 폐렴은 직접적으로 폐에 유해한 물질을 흡인했을 때 일어나며, 급성 호흡곤란, 빠른 호흡, 빠른맥이 나타나고 동반되는 증상은 주로 청색증, 기관지 경련, 열 등이다. ② 하기도의 세균성 감염이 흡인성 폐렴의 가장 흔한 형태로, 기침, 발열, 고름가래 증상을 나타낸다. ③ 하기도의 기계적 폐쇄는 특별한 물질, 특히 땅콩, 작은 고기덩어리에 의해 흡인되었을 때 일어나며, 흡인 물질과 기도의 직경에 따라 증상은 다르다. 기관에서 막히면 종종 호흡곤란과 함께 사망에 이르기도 하며, 하기도 아래 부분에서 흡인이 일어나면 만성 기침이 발생한다. |
||
| PPB | platelet-poor blood; pneumococcal pneumonia and bacteremia; positive pressure breathing |
|---|---|
| PPV | pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur... |
| AP | accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p... |
| PPS | Personal Preference Scale; physician, patient and society [course]; polyvalent pneumococcal polysacc... |
| ACIP | acute canine idiopathic polyneuropathy; Advisory Committee on Immunization Practices [CDC] |
| CII | Childhood Immunization Initiative |
|---|---|
| EPI | Expanded Program of Immunization |
| NID | National Immunization Day |
| NIS | National Immunization Survey |
| PnC | Pneumococcal C polysaccharide |
| pneumococcal pneumonia immunization | This vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
|---|
| immunization, pneumococcal pneumonia | This vaccine, which prevents one of the most common and severe forms of pneumonia, is usually given only once in a lifetime, usually after the age of 55, to someone with ongoing lung problems (such as chronic obstructive pulmonary disease (copd) or asthma) or other chronic diseases (including those involving the heart and kidneys). This vaccination would rarely be given to children. (12 Dec 1998) |
|---|---|
| pneumococcal pneumonia | Pneumonia due to infection by Streptococcus pneumoniae; often of lobar distribution. (05 Mar 2000) |
| pneumonia, pneumococcal | A febrile disease caused by streptococcus pneumoniae. This condition is characterised by inflammation of one or more lobes of the lungs and symptoms include chills, fever, rapid breathing, and cough. (12 Dec 1998) |
| meningitis, pneumococcal | Meningitis caused by bacteria of the species streptococcus pneumoniae. This condition can develop as a complication of pneumococcal pneumonia; by extension from otitis, mastoiditis, or sinusitis; following a skull injury; or without preceding sign of infection elsewhere. (12 Dec 1998) |
| pneumococcal | Pertaining to or containing the pneumococcus. (05 Mar 2000) |
| pneumococcal empyema | Infection of the pleural cavity by Streptococcus pneumoniae, the pneumococcus, with pus formation. Pulsating empyema, a large, tense collection of pus in the pleural cavity through which the cardiac pulsations are transmitted to the chest wall. Streptococcal empyema, purulent exudation into the pleural cavity caused by infection with Streptococcus haemolyticus. (05 Mar 2000) |
| pneumococcal infections | Infections with bacteria of the species streptococcus pneumoniae. (12 Dec 1998) |
| pneumococcal polysaccharide | A soluble type-specific polysaccharide produced during active growth of virulent pneumococci composing a large part of the capsule. Synonym: pneumococcal polysaccharide, soluble specific substance, specific soluble polysaccharide, specific soluble sugar. (05 Mar 2000) |
| pneumococcal/suppurative keratitis | A severe, creeping, central, suppurative ulcer often due to pneumococci. Synonym: pneumococcal/suppurative keratitis, serpent ulcer of cornea. (05 Mar 2000) |
| pneumococcal vaccine | Vaccine comprised of purified capsular polysaccharide antigen from 23 types of Streptococcus pneumoniae (representing those types responsible for most of the reported pneumococcal diseases in the U.S.). (05 Mar 2000) |
| active immunization | The production of active immunity. (05 Mar 2000) |
| anthrax immunization | A series of six shots over six months and booster shots annually, the anthrax vaccine now in use in the USA was first developed in the 1950s and approved by the Food and Drug Administration for general use in 1970. It is produced by the Michigan Biologic Products Institute of Michigan's Department of Health and is given routinely to veterinarians and others working with livestock. In December, 1997 it was announced that all US military would receive the vaccine, as do the military in the UK and Russia, the reason being concern that anthrax might be used in biologic warfare. (12 Dec 1998) |
| german measles immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (German measles). The MMR vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or MMR vaccination prior to entrance. Most children should receive MMR vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the MMR vaccine. Pregnant women should wait until after delivery before being immunised with MMR. People with HIV or AIDS should normally receive MMR vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| passive immunization | The production of passive immunity. (05 Mar 2000) |
| measles immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (german measles). The mmr vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or mmr vaccination prior to entrance. Most children should receive mmr vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the mmr vaccine. Pregnant women should wait until after delivery before being immunised with mmr. People with HIV or aids should normally receive mmr vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|